Monobactams: Clinical Trials

2 trials of Monobactams, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1
Phase 31Completed 1

Follow Monobactams: new trials by email Literature Review of Monobactams trials Research Report on Monobactams

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy
Phase 2RecruitingMassachusetts General Hospital3002025-05-052026-11-12
Use of Probiotic Lactobacilli for the Treatment of Lactational Mastitis
Lactobacillus salivarius HN6, Lactobacillus reuteri CR20, Lactobacillus fermentum LC40 - Mastitis
Phase 2 / Phase 3CompletedUniversidad Complutense de Madrid3002008-07-012009-05-25

Conditions studied

Anaphylaxis (1)  ·  Breast Feeding (1)  ·  Drug Hypersensitivity (1)  ·  Hypersensitivity (1)  ·  Mastitis (1)

Sponsors

Massachusetts General Hospital (1)  ·  Universidad Complutense de Madrid (1)

Countries

Spain (1)  ·  United States (1)

Top investigators

David A Khan, MD (1)  ·  Kimberly G Blumenthal, MD, MSc (1)

Results publications

PMID 20455694, PMID 24880136

NIH funding

U01AI184071 (1)